Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 5.1 Opinion Letter
- 8.1 Opinion Letter
- 10.13 Promissory Note, Dated March 15, 2019 Issued to KBL IV Sponsor LLC
- 10.14 Promissory Note, Dated August 21, 2019 Issued to Cannbiorx Life Sciences Corp
- 10.15 Promissory Note, Dated August 28, 2019 Issued to Cannbiorx Life Sciences Corp
- 10.16 Promissory Note, Dated September 30, 2019 Issued to Cannbiorx Life Sciences Corp
- 23.1 Consent of Withumsmith+brown, PC.
- 23.2 Consent of Marcum LLP.
- 99.1 Proxy Card
Associated filings
- 23 Oct 20 424B3 Prospectus supplement
- 13 Oct 20 EFFECT Notice of effectiveness
- 9 Oct 20 424B3 Prospectus supplement
- 28 Aug 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 10 Feb 20 S-4/A Registration of securities issued in business combination transactions (amended)
-
12 Nov 19 S-4 Registration of securities issued in business combination transactions
ATNF similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-4 of our report dated April 1, 2019, relating to the balance sheets of KBL Merger Corp. IV as of December 31, 2018 and 2017, and the related statements of operations, changes in stockholders’ equity and cash flows for the years ended December 31, 2018 and 2017, which contains an explanatory paragraph relating to substantial doubt about the ability of KBL Merger Corp. IV to continue as a going concern as described in Note 1 to the financial statements, and to the reference to our Firm under the caption “Experts” in the Registration Statement.
/s/ WithumSmith+Brown, PC | |
Whippany, New Jersey | |
November 11, 2019 |